自体单采红细胞血液质量评价指标中国专家共识

doi:10.3969/j.issn.1671-2587.2026.03.001

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (3): 305-311.DOI: 10.3969/j.issn.1671-2587.2026.03.001

• 专家共识 • 下一篇

自体单采红细胞血液质量评价指标中国专家共识

《自体单采红细胞血液质量评价指标中国专家共识》编写组

收稿日期:2026-04-21 出版日期:2026-06-20 发布日期:2026-07-07
通讯作者: 欧阳锡林（中国人民解放军总医院第四医学中心输血医学科）,主要从事术前深度单采自体储血技术和围术期血液管理,（E-mail）ouy70304@163.com。

Chinese Expert Consensus on Quality Evaluation Indicators for Autologous Apheresis Red Blood Cells

Chinese Expert Consensus Compilation Group on Quality Evaluation Indicators for Autologous Apheresis Red Blood Cells

Received:2026-04-21 Online:2026-06-20 Published:2026-07-07

摘要/Abstract

摘要： 自体单采红细胞技术作为择期手术患者自体血液资源开发的重要手段,在国内临床已开展十余年,广泛应用于重大择期手术,为缓解特殊患者用血困难提供了有效支撑。然而,当前我国尚缺乏针对自体单采红细胞关键血液质量指标的统一规范。因此,我们组织了从事输血医学包括临床输血、采供血、输血基础研究以及检验医学、麻醉学、血液学等领域的专家,采用德尔菲法及RAND/UCLA适宜性方法（RAND/UCLA appropriateness method, RAM）的量化评估,通过三轮专家咨询的共识形成方法,编写了《自体单采红细胞血液质量评价指标中国专家共识》。本共识初步建立了一套关乎自体单采红细胞血液质量的关键指标、阈值范围、监测分层与频次的质量评价标准,为各级医疗机构输血科开展自体单采红细胞业务提供了统一的血液质量评价依据,有助于实现各医疗机构间自体单采红细胞的同质化管理。

关键词: 自体单采红细胞, 质量评价指标, 专家共识, RAND/UCLA适宜性方法

Abstract: Autologous apheresis red blood cell technology is an important means for developing autologous blood resources in elective surgical patients. It has been applied in clinical practice in China for more than ten years and is widely used in major elective surgeries, providing effective support for alleviating blood supply difficulties in special patient populations. However, there is currently no unified standard in China regarding key quality indicators for autologous apheresis red blood cells. To address this, we assembled experts in the fields of transfusion medicine, including clinical transfusion, blood collection and supply, basic transfusion research, as well as laboratory medicine, anesthesiology, and hematology, to develop the "Chinese Expert Consensus on Quality Evaluation Indicators for Autologous Apheresis Red Blood Cells" using a three-round consensus formation method based on expert consultation combined with the Delphi method and the RAND/UCLA Appropriateness Methods (RAM) for quantitative assessment. This consensus preliminarily establishes a set of quality evaluation standards for assessing the blood quality of autologous apheresis red blood cells, including key evaluation indicators, threshold ranges, monitoring stratification, and testing frequency. It provides a unified basis for blood transfusion departments in medical institutions at various levels to evaluate the quality of autologous apheresis red blood cells, and facilitates the homogenized management of such products across different institutions.

Key words: Autologous apheresis red blood cells, Quality evaluation indicators, Expert consensus, RAND/UCLA appropriateness method

中图分类号:

R457.1

《自体单采红细胞血液质量评价指标中国专家共识》编写组. 自体单采红细胞血液质量评价指标中国专家共识[J]. 临床输血与检验, 2026, 28(3): 305-311.

Chinese Expert Consensus Compilation Group on Quality Evaluation Indicators for Autologous Apheresis Red Blood Cells. Chinese Expert Consensus on Quality Evaluation Indicators for Autologous Apheresis Red Blood Cells[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2026, 28(3): 305-311.

参考文献

[1] 国家卫生健康委员会.临床用血技术规范(2025年版)[Z].北京:国家卫生健康委员会, 2025.
[2] 国家卫生健康委员会. 围手术期患者血液管理指南:WS/T 796—2022[S]. 北京:中国标准出版社,2022.
[3] 中国输血协会临床输血管理学专业委员会. 术前深度单采自体红细胞和/或血小板储血技术应用中国专家共识[J]. 临床输血与检验,2024,26(2):145-155.
[4] European Directorate for the Quality of Medicines and HealthCare. Guide to the preparation, use and quality assurance of blood components:Appendix to Recommendation No. R (95) 15 of the Committee of Ministers to member states[M]. 21st ed.Strasbourg:Council of Europe,2023.
[5] NHS Blood and Transplant. NHSBT portfolio of blood components and guidance for their clinical use[M]. 2025th ed.Bristol:NHSBT,2025.
[6] Cohn C S,Delaney M,Johnson S T,et al.AABB技术手册[M].20版.桂嵘,陈秉宇,黄远帅,等主译.长沙:中南大学出版社,2022.
[7] 国家质量监督检验检疫总局,中国国家标准化管理委员会. 全血及成分血质量要求:GB 18469—2012[S]. 北京:中国标准出版社,2012.
[8] 中华人民共和国国家卫生和计划生育委员会. 全血及成分血质量监测指南:WS/T 550—2017[S]. 北京:中国标准出版社,2017.
[9] Holme S,Elfath M D,Whitley P.Evaluation of in vivo and in vitro quality of apheresis-collected RBC stored for 42 days[J]. Vox Sang,1998,75(3):212-217.
[10] Matthes G A.Red cell apheresis:new concepts of blood component processing[J]. Ther Apher,1997,1(1):22-28.
[11] Komatsu F,Kajiwara M.A pilot study of large volume apheresis of red blood cells and plasma during one donation by allogeneic blood donors[J]. Transfus Sci, 2000,23(1):55-61.
[12] Moog R,Franck V,Pierce J A,et al.Evaluation of a concurrent multicomponent collection system for the collection and storage of WBC-reduced RBC apheresis concentrates[J]. Transfusion,2001,41(9):1159-1164.
[13] Leitner G C,Jilma-Stohlawetz P,Stiegler G,et al.Quality of packed red blood cells and platelet concentrates collected by multicomponent collection using the MCS plus device[J]. J Clin Apher,2003,18(1):21-25.
[14] Rock G,Moltzan C,Alharbi A,et al.Automated collection of blood components:their storage and transfusion[J]. Transfus Med,2003,13(4):219-225.
[15] Harrison J F.Automated red cell collection-quality and value[J]. Transfus Med,2006,16(3):155-164.
[16] Picker S M,Radojska S M,Gathof B S.In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage[J]. Transfusion,2007,47(4):687-696.
[17] Thomas S,Bekoe Y,Uddin S,et al.Double red cell concentrates-in vitro quality after delayed refrigeration[J]. Transfus Med,2010,20(5):315-321.
[18] Radwanski K,Cognasse F,Garraud O,et al.Comparison of apheresis and 24 h RT held red cell concentrates by measurement of storage lesion parameters and neutrophil activating factors during 42-day storage[J]. Transfus Apher Sci,2013,48(2):169.
[19] Hussein E,Enein A.Clinical and quality evaluation of red blood cell units collected via apheresis versus those obtained manually[J]. Lab Med,2014,45(3):238-243.
[20] Matthes G,Tofote U,Krause K P,et al.Improved red cell quality after erythroplasmapheresis with MCS-3P[J]. J Clin Apher,1994,9(3):183-188.
[21] Valbonesi M,Bruni R,Florio G,et al.Evaluation of dosed red blood cell units collected with Gambro BCT—TRIMA[J]. Transfus Apher Sci,2001,24(1):65-70.
[22] Picker S M,Radojska S M,Gathof B S.Prospective evaluation of double RBC collection using three different apheresis systems[J]. Transfus Apher Sci,2006, 35(3):197-205.
[23] Aubuchon J P,Dumont L J,Herschel L,et al.Automated collection of double red blood cell units with a variable-volume separation chamber[J]. Transfusion,2008,48(1):147-152.
[24] Matthes G,Ingilizov M,Dobao M L,et al.Red cell apheresis with automated in-line filtration[J]. Transfus Med Hemother,2014,41(2):107-113.
[25] Bandarenko N,Rose M,Kowalsky R J,et al.In vivo and in vitro characteristics of double units of RBCs collected by apheresis with a single in-line WBC-reduction filter[J]. Transfusion,2001,41(11):1373-1377.
[26] Moog R,Bartsch R,Müller N.Concurrent collection of in-line filtered platelets and red blood cells by apheresis[J]. Ann Hematol,2002,81(6):322-325.
[27] Radojska S M,Picker S M,Gathof B S.Comparison of in vitro characteristics of leukodepleted red blood cells (RBCs) derived from apheresis:impact of filter performance[J]. Transfus Med Hemother,2006,33(5):459-465.
[28] Bohoněk M,Petráš M,Turek I,et al.In vitro parameters of cryopreserved leucodepleted and non-leucodepleted red blood cells collected by apheresis or from whole blood and stored in AS-3 for 21 days after thawing[J]. Trasfusione Del Sangue,2014,12(Suppl 1):s199-s203.
[29] Mendrone A Jr,Arrais C A,Almeida Neto C,et al.Impact of allogeneic 2-RBC apheresis on iron stores of Brazilian blood donors[J]. Transfus Apher Sci,2009, 41(1):13-17.
[30] Shi P A,Ness P M.Two-unit red cell apheresis and its potential advantages over traditional whole-blood donation[J]. Transfusion,1999,39(2):218-225.
[31] Guyatt G H,Oxman A D,Vist G E,et al.GRADE:an emerging consensus on rating quality of evidence and strength of recommendations[J]. Bmj,2008,336(7650):924-926.
[32] The Joanna Briggs Institute Levels of Evidence and Grades of Recommendation Working Party. Supporting document for the Joanna Briggs Institute levels of evidence and grades of recommendation[EB/OL].(2014-01).https://jbi.global/sites/default/files/2020-07/Supporting_Doc_JBI_Levels_of_Evidence_Grades_of_Recommendation.pdf.

自体单采红细胞血液质量评价指标中国专家共识

Chinese Expert Consensus on Quality Evaluation Indicators for Autologous Apheresis Red Blood Cells

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	长三角一体化临床输血质量控制与管理联合体, 上海市临床输血质量控制中心, 上海市社会医疗机构协会输血专业委员会, 上海市医学会输血专科分会, 上海市医师协会输血科医师分会. 临床输血全流程清单式质量管理专家共识[J]. 临床输血与检验, 2026, 28(2): 153-161.
[2]	《中国输血患者RhCE抗原配型专家共识》编写组. 中国输血患者RhCE抗原配型专家共识[J]. 临床输血与检验, 2026, 28(2): 161-167.
[3]	华东地区采供血机构协作组共识项目专家组. 采供血机构血液和环境卫生质量检查中国专家共识^*[J]. 临床输血与检验, 2026, 28(1): 9-17.
[4]	《输血科（血库）输血前检测相关设备试剂使用与人员检测能力规范管理中国专家共识》编写组. 输血科（血库）输血前检测相关设备试剂使用与人员检测能力规范管理中国专家共识^*[J]. 临床输血与检验, 2025, 27(6): 745-753.
[5]	中国输血协会临床输血管理学专业委员会, 中华医学会血液学分会, 中国药师协会肿瘤药师分会. 靶向药物导致血液系统异常的输血与药物治疗中国专家共识^*[J]. 临床输血与检验, 2025, 27(1): 1-12.
[6]	红细胞血型抗原拓展匹配适用范围中国专家共识编写组. 红细胞血型抗原拓展匹配适用范围中国专家共识[J]. 临床输血与检验, 2024, 26(3): 289-298.
[7]	中国输血协会临床输血管理学专业委员会. 术前深度单采自体红细胞和/或血小板储血技术应用中国专家共识[J]. 临床输血与检验, 2024, 26(2): 145-155.
[8]	红细胞意外抗体筛查与鉴定抗原谱构成中国专家共识起草编写组. 红细胞意外抗体筛查与鉴定抗原谱构成中国专家共识[J]. 临床输血与检验, 2024, 26(2): 156-163.
[9]	中国生物医学工程学会血液疗法与工程分会, 中国整形美容协会毛发医学分会, 富血小板血浆创新技术脱发治疗项目组. 自体单采富血小板血浆在脱发治疗中的临床应用专家共识^*[J]. 临床输血与检验, 2024, 26(1): 1-7.
[10]	中国输血协会临床输血管理学专业委员会. 婴儿期输血前红细胞血型血清学检测中国专家共识^*[J]. 临床输血与检验, 2024, 26(1): 8-16.
[11]	《输血相关急性肺损伤诊治中国专家共识》编写组. 输血相关急性肺损伤诊治中国专家共识（2023版）[J]. 临床输血与检验, 2023, 25(5): 577-585.
[12]	异基因造血干细胞移植临床输血专家共识起草专家组. 异基因造血干细胞移植临床输血专家共识[J]. 临床输血与检验, 2023, 25(5): 586-593.
[13]	上海市医学会输血专科分会, 上海市临床输血质控中心. 医疗机构内物流系统血液运送的应用及管理上海专家共识[J]. 临床输血与检验, 2023, 25(4): 433-438.
[14]	中国输血协会临床输血管理学专业委员会. 自体单采富血小板血浆治疗薄型子宫内膜的专家共识[J]. 临床输血与检验, 2023, 25(3): 289-296.
[15]	中国输血协会临床输血管理学专业委员会. 重型和危重型COVID-19患者血液成分安全输注专家共识^*[J]. 临床输血与检验, 2023, 25(2): 149-162.